|
Abraham RT, Acquarone M, Andersen A, Asensi A, Belle R, Berger F, Bergounioux C, Brunn G, Buquet-Fagot C and Fagot D. 1995. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biol. Cell 83: 105-120
Aderem A, Ulevitch RJ. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-7
Aiello S, Noris M, Piccinini G, Tomasoni S, Casiraghi F, Bonazzola S, Mister M, Sayegh MH, Remuzzi G. 2000. Thymic Dendritic Cells Express Inducible Nitric Oxide Synthase and Generate Nitric Oxide in Response to Self- and Alloantigens. J. Immunol. 164: 4649–58
Akira S, Takeda K. 2004. TOLL-LIKE RECEPTOR SIGNALLING. Nat. Rev. Immunol. 4: 499-511
Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR. 1999. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J. Clin. Invest. 104:1631–1639
Andrews, D.M. et al. 2003. Functional interactions between dendritic
cells and NK cells during viral infection. Nat. Immunol. 4, 175–181
Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392: 245-52
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y-J, Pulendran B, Palucka K. 2000. IMMUNOBIOLOGY OF DENDRITIC CELLS. Annu. Rev. Immunol. 18: 767–811
Banchereau J, Palucka AK. 2005. DENDRITIC CELLS AS THERAPEUTIC VACCINES AGAINST CANCER. Nat. Rev. Immunol. 5: 296-306
Baranano DE, Snyder SH. 2001. Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 98: 10996–11002
Bhardwaj N, M.D., Ph.D. 2003. The modulation of immunity by dendritic cells. Clinical and Applied Immunology Reviews 3: 173-82
Bohnenkamp HR, Burchell JM, Taylor-Papadimitrioub J, Nolla T. 2004. Apoptosis of monocytes and the influence on yield of monocyte
-derived dendritic cells. J. Immunol. Methods 294: 67-80
Bredt D S, Hwang P M, Glatt, C E, Lowenstein C, Reed R R & Snyder S H. 1991. Cloned and expressed nitric oxide synthase structurally
resembles cytochrome-P450 reductase. Nature 351: 714–
718
Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, and Soares MP. 2000. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J. Exp. Med. 192:1015–1026
Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, and Soares MP. 2002. Heme oxygenase-1 derived carbon monoxide requires the activation of the transcription factor NF-kB to protect endothelial cells from TNF-alpha mediated apoptosis. J. Biol. Chem. 277: 17950–17961
Camara NOS, Soares MP. 2005. Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic. Biol. Med. 38: 426-35
Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, Saint-Vis
B, Jacquet C, Yoneda K, Imamura S, Schmitt D, Banchereau J. 1996. CD34+ hematopoietic progenitors from human cord blood
differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 184: 695-706
Chan FK, Zhang J, Cheng L, Shapiro DN and Winoto A. 1995. Identification of human/mouse p19, a novel CDK4/CDK6 inhibitor with homology to p16ink4. Mol. Cell. Biol. 15：2682–2688
Chang L, Karin M. 2001. Mammalian MAP kinase signalling cascades. Nature 410: 37-40
Chauveau C, Remy S, Royer PJ, Hill M, Tanguy-Royer S, Hubert F-X, Tesson L, Brion R, Beriou G, Gregoire M, Josien R, Cuturi MC, Anegon I. 2005. Heme oxygenase-1 expression inhibits dendritic cell maturation and pro-inflammatory function but conserves IL-10 expression. Blood DOI 10.1182/blood-2005-02-0494: 1-37
Chen J, Saha P, Kornbluth S, Dynlacht BD and Dutta A. 1996. Cyclin- binding motifs are essential for the function of p21Cip1. Mol. Cell. Biol. 16: 4673–4682
Clark JE, Foresti R, Green CJ, Motterlini R. 2000. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem. J. 348: 615–619
Colonna M, Krug A, Cella M. 2002. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 14: 373–9
Creusot RJ, Mitchison NA. 2004. How DCs control cross-regulation
between lymphocytes. Trends Immunol. 25: 126-31
Dawson T M, Snyder SH, 1994. Gases as biological messengers: nitric
oxide and carbon monoxide in the brain. J. Neurosci. 14, 5147–
5159
Fehsel, K., K. D. Kroncke, K. L. Meyer, H. Huber, V. Wahn, and
V. Kolb-Bachofen. 1995. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155: 2858.
FERNANDEZ NC, LOZIER A, FLAMENT C, RICCIARDI
-CASTAGNOLI P, BELLET D, SUTER M, PERRICAUDET M, TURSZ T, MARASKOVSKY E, ZITVOGEL L. 1999. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5: 405-11
Fujii S-i, Liu K, Smith C, Bonito AJ, Steinman RM. 2004. The Linkage of Innate to Adaptive Immunity via Maturing Dendritic Cells In Vivo Requires CD40 Ligation in Addition to Antigen Presentation and CD80/86 Costimulation. J. Exp. Med. 199: 1607-18
Galea E, Feinstein D L and Reis D J. 1992. Induction of calcium
-independent nitric oxide synthase activity in primary rat glial
cultures. Proc. Natl. Acad. Sci. USA 89: 10945-10949
Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. 2002. Reciprocal Activating Interaction between Natural Killer
Cells and Dendritic Cells. J. Exp. Med. 195: 327-33
Glab N, Labidi B, Qin LX, Trehin C, Bergounioux C and Meijer L. 1994. Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions. FEBS Lett. 2：207-211
GRISHAM MB, JOURD’HEUIL D, WINK DA. 1999. Nitric Oxide
I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol. 276: G315-G21
Gu Y, Turck CW and Morgan DO. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366：707–710
Hannon GJ and Beach D. 1994. p15INK4b is a potential effector of TGFβ-induced cell cycle arrest. Nature 371：257–261
Hilkens CM, Kalinski P, de Boer M, Kapsenberg ML. 1997. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90: 1920-1926
Hirai H, Roussel MF, Kato JY, Ashmun RA and Sherr CJ. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15: 2672–2681
Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J, Nath KA. 2001. Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int. 60: 2181–2191
Kampgen E, Koch F, Heufler C, Eggert A, Gill LL, Gillis S, Dower SK, Romani N, Schuler G. 1994. Understanding the dendritic ell lineage through a study of cytokine receptors. J. Exp. Med. 179: 1767-1776
Ke B, Shen XD, Zhai Y, Gao F, Busuttil RW, Volk HD, Kupiec-Weglinski JW. 2002. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum. Gene Ther. 13: 1845–1857
Kelleher M, Beverley PCL. 2001. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+T cells in vitro, whereas CD40
ligation is essential. J. Immunol. 167: 6247–55
Kriehuber E, Bauer W, Charbonnier A-S, Winter D, Amatschek S, Tamandl D, Schweifer N, Stingl G, Maurer D. 2005. The balance between NF-kB and JNK/AP-1 activity controls dendritic cell life and death. Blood DOI 10.1182/blood-2004-08-3072: 1-43
Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T, Grabbe S. 1999. Generation of Tumor Immunity by Bone Marrow-Derived
Dendritic Cells Correlates with Dendritic Cell Maturation Stage. J. Immunol. 162: 168–75
Landmann S, Muhlethaler-Mottet A, Bernasconi L, Suter T, Waldburger J-M, Masternak K, Arrighi J-F, Hauser C, Fontana A, Reith W. 2001. Maturation of Dendritic Cells Is Accompanied by Rapid Transcriptional Silencing of Class II Transactivator (CIITA) Expression. J. Exp. Med. 194: 379-91
Lee MH, Reynisdottir I and Massague J. 1995. Cloning of p57Kip2, a
cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9: 639–649
Lee TS, Chau LY. 2002. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8: 240-246
Liu N, Wang X, McCoubrey WK, and Maines MD. 2000. Developmentally regulated expression of two transcripts for heme oxygenase-2 with a first exon unique to rat testis: control by corticosterone of the oxygenase protein expression. Gene 241: 175–183
Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, Masterman K-A, Maliszewski C, Shortman K, Cebon J, Maraskovsky E. 2002. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets. Blood 100: 1362-72
Lutz MB, Kukutsch N, Ogilivie A. LJ, Roβner S, Koch F, Romani N, Schuler G. 1999. An advanced culture method for generating quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92
Maines MD. 1997. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37:517–554
Maldonado-Lopez R, Smedt TD, Michel P, Godfroid J, Pajak B, Heirman C, Thielemans K, Leo O, Urbain J, Moser aM. 1999. CD8 alpha+ and CD8 alpha – subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189: 587-92
Maraskovsky E, Brasel K, Teepe M, Roux E.R, Lyman SD, Shortman K, McKenna HJ. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic subpopulations identified. J. Exp. Med. 184: 1953-1962
Marletta MA. 1989. Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci. 12: 488-92
Marletta MA. 1994. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78: 927–930
Matsue H, Edelbaum D, Shalhevet D, Mizumoto N, Yang C, Mummert ME, Oeda J, Masayasu H, Takashima A. 2003. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 171: 3010-3018
Matsunaga T, Ishida T, Takekawa M, Nishimura S, Adachi M, Imai K. 2002. Analysis of gene expression during maturation of immature dendritic cells derived from peripheral blood monocytes. Scand J. Immunol. 56: 593-601.
Mattei F, Schiavoni G, Belardelli F, Tough DF. 2001. IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation. J. Immunol. 167: 1179–1187
McConnell BB, Gregory FJ, Stott FJ, Hara E and Peters G. 1999. Induced expression of p16INK4a inhibits both CDK4 and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell. Biol. 19：1981–1989
McDaid J, Yamashita K, Chora A, Öllinger R, Strom TB, Li XC, Bach FH, Soares MP. 2005. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. FASEB J. doi:10.1096/fj.04-2217fje
McRae BL, Semnani RT, Hayes MP, van Seventer GA. 1998. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell
development. J. Immunol. 160: 4298-4304
Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell’Acqua G, Mann MJ, Oyama J. 2002. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105: 602–607
Michelle Kelleher, Peter C. L. Beverley. 2001. Lipopolysaccharide Modulation of Dendritic Cells Is Insufficient to Mature Dendritic Cells to Generate CTLs from Naive Polyclonal CD8+ T Cells In Vitro, Whereas CD40 Ligation Is Essential. J. Immunol. 167: 6247–6255
Moncada S, Higgs EA. 1991. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest. 4: 361-374
Montellano PR. 2000. The mechanism of heme oxygenase. Curr Opin Chem Biol 4:221–227.
Morse D, Choi AMK. 2002. Heme Oxygenase-1 The “Emerging Molecule” Has Arrived. Am. J. Respir. Cell Mol. Biol. 27: 8–16
Munder M., K. Eichmann, M. Modolell. 1998. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD41 T cells correlates with Th1/Th2 phenotype. J. Immunol. 160: 5347.
Munder M, Eichmann K, Mora´n JM, Centeno F, Soler Gn, Modolell M. 1999. Th1/Th2-Regulated Expression of Arginase Isoforms in Murine Macrophages and Dendritic Cells. J. Immunol. 163: 3771–7
Nathan CF, Hibbs JB Jr. 1991. Role of nitric oxide synthesis in macrophage anti-microbial activity. Curr. Opin. Immunol. 1: 65-70
Nathan C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 12: 3051-64
Nathan C, Xie QW. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915–918
Nestle FO, Farkas A, Conrad C. 2005. Dendritic-cell-based therapeutic vaccination against cancer. Curr. Opin. Immunol. 17: 163–9
Nguyen, V. T., E. N. Benveniste. 2002. Critical role of TNF- and NF-B in IFN--induced CD40 expression in microglia/macrophages. J. Biol. Chem. 277: 13796-13803
Otterbein LE. Choi AMK. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. 2000; 279: L1029–L1037
Otterbein LE. Soares MP. Yamashita K. Bach FH. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24: 449.
Otterbein LE. Bach FH. Alam J. Soares M. Tao Lu H. Wysk M. Davis RJ. Flavell RA. Choi AM. 2000. Carbon monoxide has anti-inflammatory effects involving the mitogenactivated protein kinase pathway. Nat Med. 6: 422-428
Pae H-O, Oh G-S, Choi B-M, Chae S-C, Kim Y-M, Chung K-R, Chung H-T. 2004. Carbon Monoxide Produced by Heme Oxygenase-1 Suppresses T cell Proliferation via Inhibition of IL-2 Production. J. Immunol. 172: 4744–51
Parry D. Bates S. Mann DJ. Peters G. 1995. Lack of cyclin D-cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumor suppressor gene product. EMBO J. 14: 503–511
Parry D, Mahony D, Wills K and Lees E. 1999. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol. Cell. Biol. 19: 1775–1783
Piccioli D. Sbrana S. Melandri E. Valiante NM. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195: 335–341
Poss KD. Tonegawa S. 1997. Reduced stress defense in heme oxygenase
1-deficient cells. Proc. Natl. Acad. Sci. USA 94: 10925
PULENDRAN B, SMITH JL, G.CASPARY, BRASEL K, PETTIT D, E.MARASKOVSKY, MALISZEWSKI CR. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96: 1036-41
Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, Malefyt RdW, Liu Y-J. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183-6
Romani N. Gruner S. Brang D. Kampgen E. Lenz A. Trockenbacher B. Konwalinka G. Fritsch PO. Steinman RM. Schuler G. 1994 . Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83-93
Russo AA. Jeffrey PD. Patten AK. Massague J. Pavletich NP. 1996. Crystal structure of the p27Kip1 cyclin-dependent kinase inhibitor bound to the cyclin A-cdk2 complex. Nature 382: 325–331
S.K.Walker L, Abbas AK. 2002. THE ENEMY WITHIN: KEEPING SELF-REACTIVE T CELLS AT BAY IN THE PERIPHERY. Nat. Rev. Immunol. 2: 11-9
Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G. 2001. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J. Immunol. 166: 4185–4194
Scandella E, Men Y, Gillessen S, rster RFL, Groettrup M. 2002. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100: 1354-61
Schnurr M, Then F, Galambos P, Scholz C, Siegmund B, Endres S, Eigler A. 2000. Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J. Immunol. 165: 4704-9
Serrano M. Hannon GJ. Beach D.1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/CDK4. Nature 366: 704–707.
Shortman K, Liu Y-J. 2002. MOUSE AND HUMAN DENDRITIC CELL SUBTYPES. Nat. Rev. Immunol. 2: 151-61
Smits HH, Jong EC, Wierenga EA, Kapsenberg ML. 2005. Different faces of regulatory DCs in homeostasis and immunity. Trends Immunol. 26: 123-9
Son Y-I, Egawa S-i, Tatsumi T, E. R, Jr. R, Kalinski P, Kanto T. 2002. A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J. Immunol. Methods 262: 145-57
Song R, Mahidhara RS, Zhou Z, Hoffman RA, Seol D-W, Flavell RA, Billiar TR, Otterbein LE, Choi AMK. 2004. Carbon Monoxide Inhibits T Lymphocyte Proliferation via Caspase-Dependent Pathway. J. Immunol. 172: 1220–6
STOCKWIN LH, McGONAGLE D, MARTIN IG, BLAIR GE. 2000. Dendritic cells: Immunological sentinels with a central role in health and disease. Immunol. Cell Biol. 78: 91–102
Szabolcs P. Moore MA. Young JW. 1995. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-Kit ligand, granulocyte macrophage colony-stimulating factor, and TNF-alpha. J. Immunol. 154: 5851-5861
Todd I. 2001. Cells of the Immune System. ENCYCLOPEDIA OF LIFE SCIENCES
Torti FM , Torti SV. 2002. Regulation of ferritin genes and protein. Blood 99: 3505–3516
Toyoshima H. Hunter T. 1994. p27, a novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21. Cell 78: 67–74
Ulevitch RJ. 2000. Molecular Mechanisms of Innate Immunity. Immunol. Res. 21: 49-54
Vegh Z, Mazumder A. 2003. Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response. Cancer Immunol. Immunother. 52: 67-79
Verhasselt V, Vanden Berghe W, Vanderheyde N, Willems F, Haegeman G, Goldman M. 1999. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J. Immunol. 162: 2569-2574
Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. 2000. CD4 and CD8 Expression by Dendritic Cell Subtypes in Mouse Thymus and Spleen. J. Immunol. 164: 2978–86
Wesemann DR, Dong Y, O’Keefe GM, Nguyen VT, Benveniste EN. 2002. Suppressor of Cytokine Signaling 1 Inhibits Cytokine Induction of CD40 Expression in Macrophages. J. Immunol. 169: 2354–60
Whiteside TL, Odoux C. 2004. Dendritic cell biology and cancer therapy. Cancer Immunol. Immunother. 53: 240–8
Willoughby DA, Moore AR, Colville-Nash PR, Gilroy D. 2000. Resolution of inflammation. Int. J. Immunopharmacol. 22: 1131–1135
Woltman AM, Kooij SWvd, Coffer PJ, Offringa R, Daha MR, Kooten Cv. 2003. Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression. Blood 101: 1439-45
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D . 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701–704
Yang L, Quan S, and Abraham NG. 1999. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am. J. Physiol. 277: L127–L133
Yu Y, Hagihara M, Ando K, Gansuvd B, Matsuzawa H, Tsuchiya T, Ueda Y, Inoue H, Hotta T, Kato S. 2001. Enhancement of Human Cord Blood CD34+ Cell-Derived NK Cell Cytotoxicity by Dendritic Cells. J. Immunol. 166: 1590–600
Zsuzsa Vegh, Amitabha Mazumder. 2003. Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response. Cancer Immunol. Immunother. 52: 67–79
|